Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial

Pediatrics

Volumn 105, Issue 5, 2000, Pages 1066-1072

  Donato, Hugo ^a   Vain, Nestor ^b,g   Rendo, Pablo ^a   Vivas, Norma ^h   Prudent, Luis ^c,e   Larguía, Miguel ^f   Digregorio, Jorge ^d   Vecchiarelli, Carmen ^e   Valverde, Regina ^g   García, Cecilia ^b   Subotovsky, Patricia ^c   Solana, Claudio ^f   Gorenstein, Adriana ^h  

^a Bio Sidus   (Argentina)

^b Sanatorio de la Trinidad   (Argentina)

^c Clinica y Maternidad Suizo Argentina   (Argentina)

^d Inst Médico de Obstetricia   (Argentina)

^e Sanatorio Otamendi   (Argentina)

^f Division of Pulmonary Diseases   (Argentina)

^g Sanatorio Jockey Club   (Argentina)

^h Clinica Independencia Buenos Aires   (Argentina)

Author keywords

Anemia; Erythropoietin; Prematurity; Thrombocytosis; Transfusion

Indexed keywords

FOLIC ACID; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHRONOPHARMACOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN; PHLEBOTOMY; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; THROMBOCYTOPENIA; VERY LOW BIRTH WEIGHT;

EID: 0034016133     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.105.5.1066     Document Type: Article

References (51)

1. Stockman JA III, García JF, Oski FA. The anemia of prematurity: factors governing the erythropoietin response. N Engl J Med. 1977;296:647-650
2. Brown MS, Phibbs RH, García JF, Dallman PR. Postnatal changes in erythropoietin levels in untransfused premature infants. J Pediatr. 1983; 103:612-617
3. Stockman JA III, Graeber JE, Clark DA, et al. Anemia of prematurity: Determinants of erythropoietin response. J Pediatr. 1984;105:786-792
4. Brown MS, García JF, Phibbs RH, Dallman PR. Decreased response of plasma immunoreactive erythropoietin to available oxygen in anemia of prematurity. J Pediatr. 1984;105:793-798
5. Ruth V, Widness JA, Clemons G, Raivio KO. Postnatal changes in serum immunoreactive erythropoietin in relation to hypoxia before and after birth. J Pediatr. 1990;116:959-1054
6. Yamashita H, Kukita J, Ohga S, et al. Serum erythropoietin levels in term and preterm infants during the first year of life. Am J Pediatr Hematol Oncol. 1994;16:213-218
7. Shannon KM, Naylor GS, Torkildson JC, et al. Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med. 1987;317: 728-733
8. Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity." J Pediatr. 1988;112:935-940
9. Emmerson AJB, Westwood NB, Rackman RA, Stern CM, Pearson TC. Erythropoietin responsive progenitors in anaemia of prematurity. Arch Dis Child. 1991;66:810-816
10. Forestier F, Daffos F, Catherine N, Renard M, Andreux JP. Developmental hematopoiesis in normal human fetal blood. Blood. 1991;77: 2360-2363
11. Halperin DS, Wacker P, Lacourt G, et al. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr. 1990;116:779-786
12. Ohls RK, Christensen RD. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr. 1991;119:781-788
13. Halperin DS, Felix M, Wacker P, Lacourt G, Babel JF, Wyss M. Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity. Eur J Pediatr. 1992;151:661-667
14. Beck D, Masserey E, Meyer M, Calame A. Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity. Eur J Pediatr. 1991;150:767-772
15. Shannon KM, Mentzer WC, Abels RI, et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr. 1991;118:949-955
16. Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr. 1992;121:98-102
17. Messer J, Haddad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics. 1993;92:519-523
18. Emmerson AJB, Coles HJ, Stern CMM, Pearson TC. Double-blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child. 1993;68:291-296
19. Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res. 1993;34:675-679
20. Meyer MP, Meyer JH, Commeford A, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics. 1994;93:918-923
21. Maier RF, Obladen M, Scigalla P, et al. The effect of epoetin-β (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med. 1994;330:1173-1178
22. Shannon KM, Keith JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics. 1995;95:1-8
23. Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr. 1995;126:421-426
24. Chen JY, Wu TS, Chanlai SP. Recombinant human erythropoietin in the treatment of anemia of prematurity. Am J Perinatol. 1995;12:314-316
25. Donato H, Rendo P, Vivas N, et al. Recombinant human erythropoietin in the treatment of anemia of prematurity: a randomized, double-blind, placebo-controlled trial comparing three different doses. Int J Pediatr Hematol Oncol. 1996;3:279-285
26. Ohls RK, Veerman MW, Christensen RD. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution. J Pediatr. 1996;128:518-523
27. Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr. 1997;131:661-665
28. Doyle JJ. The role of erythropoietin in the anemia of prematurity. Semin Perinatol. 1997;21:20-27
29. Strauss RG. Transfusion therapy in neonates. Am J Dis Child. 1991;145: 904-911
30. Kim HC. Red blood cell transfusion in the neonate. Semin Perinatol. 1983;7:159-174
31. Blanchette VS, Zipursky A. Assessment of anemia in newborn infants. Clin Perinatol. 1984;11:489-510
32. Sacher RA, Luban NLC, Strauss RG. Current practice and guidelines for the transfusion of cellular blood components in the newborn. Transfus Med Rev. 1989;3:39-54
33. Brown MS, Berman ER, Luckey D. Prediction of the need for transfusion during anemia of prematurity. J Pediatr. 1990;116:773-778
34. Lujan S, Solana C, Larguía M. Transfusiones de productos sanguineos en neonatos de muy bajo peso al nacer. Arch Argent Pediatr. 1994;92: 147-151
35. Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol. 1995;22:641-655
36. Bifano EM, Curran TR. Minimizing donor blood exposure in the neonatal intensive care unit: current trends and future prospects. Clin Perinatol. 1995;22:657-669
37. Gallagher PG, Ehrenkranz RA. Erythropoietin therapy for anemia of prematurity. Clin Perinatol. 1993;20:169-191
38. Shannon K. Recombinant erythropoietin in anemia of prematurity: five years later. Pediatrics. 1993;92:614-616
39. Asch J, Wedgwood JF. Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy? J Perinatol. 1997;17:276-282
40. Migliaccio AR, Migliaccio G. Human embryonic hemopoiesis: control mechanisms underlying progenitor differentiation in vitro. Dev Biol. 1988;125:127-134
41. Dessypris EN, Graber SE, Krantz SB, Stone WJ. Effects of recombinant erythropoietin on human marrow hematopoietic progenitors in vivo. Blood. 1987;70:132A
42. Christensen RD, Koenig JM, Viskochil DH, Rothstein G. Down-modulation of neutrophil production by erythropoietin in human haematopoietic clones. Blood. 1989;74:817-822
43. Christensen RD, Rothstein G. Erythropoietin affects the maturation pattern of fetal G-CSF-responsive progenitors. Am J Hematol. 1992;39:108-112
44. Dallman PR. Anemia of prematurity. Ann Rev Med. 1981;32:143-160
45. Andrews NC, Bridges KR. Disorders of iron metabolism and sideroblastic anemia. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of Infancy and Childhood, I. Philadelphia, PA: WB Saunders Co; 1998:440
46. Kaushansky K. Thrombopoietin. N Engl J Med. 1998;339:746-754
47. Sohma Y, Akahori H, Seki N, et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett. 1994;353: 57-61
48. Foster DC, Sprecher CA, Grant FJ, et al. Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA. 1994;91:13023-13027
49. Gurney A, Kuang WJ, Xie MH, et al. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood. 1995;85:981-988
50. Kaushansky K, Broudy VC, Grossman A, et al. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest. 1995;96:1683-1687
51. Kaushansky K, Lin N, Grossman A, et al. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells in normal and myelosuppressed mice. Exp Hematol. 1996;23: 265-269